MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-02-20
Last Posted Date
2016-07-20
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
587
Registration Number
NCT00003299
Locations
🇺🇸

CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States

🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 17 locations

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Phase 3
Completed
Conditions
Chronic Myeloproliferative Disorders
Anemia
Drug/Agent Toxicity by Tissue/Organ
Leukemia
Multiple Myeloma and Plasma Cell Neoplasm
Unspecified Adult Solid Tumor, Protocol Specific
Small Intestine Cancer
Breast Cancer
Lung Cancer
Lymphoma
Interventions
Other: placebo
Biological: epoetin alfa
First Posted Date
2004-02-20
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
344
Registration Number
NCT00003600
Locations
🇺🇸

Howard University Cancer Center, Washington, District of Columbia, United States

🇺🇸

CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States

🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

and more 18 locations

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Phase 3
Completed
Conditions
Bladder Cancer
Interventions
Other: Placebo
Dietary Supplement: multivitamin
First Posted Date
2004-02-20
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
21
Registration Number
NCT00003623
Locations
🇺🇸

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

🇺🇸

CCOP - Wichita, Wichita, Kansas, United States

🇺🇸

CCOP - Toledo Community Hospital Oncology Program, Toledo, Ohio, United States

and more 14 locations

Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

Completed
Conditions
Lung Cancer
Interventions
Genetic: proteomic profiling
Other: surface-enhanced laser desorption/ionization-time of flight mass spectrometry
Procedure: biopsy
Procedure: surgery
First Posted Date
2004-02-12
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1000
Registration Number
NCT00077324
Locations
🇺🇸

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States

🇺🇸

Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

🇺🇸

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

and more 70 locations

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Anemia
Drug/Agent Toxicity by Tissue/Organ
Lung Cancer
Neutropenia
Interventions
Biological: darbepoetin alfa
Biological: pegfilgrastim
Drug: cisplatin
Drug: docetaxel
Drug: BNP7787
First Posted Date
2004-02-12
Last Posted Date
2016-06-30
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
160
Registration Number
NCT00077311
Locations
🇺🇸

Graham Hospital, Canton, Illinois, United States

🇺🇸

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

🇺🇸

Veterans Affairs Medical Center - Baltimore, Baltimore, Maryland, United States

and more 61 locations

Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Phase 2
Completed
Conditions
Metastatic Cancer
Melanoma (Skin)
Interventions
Biological: sargramostim
First Posted Date
2004-02-12
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
28
Registration Number
NCT00005610
Locations
🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

CCOP - Duluth, Duluth, Minnesota, United States

🇺🇸

CentraCare Clinic, Saint Cloud, Minnesota, United States

and more 15 locations

FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

Phase 3
Terminated
Conditions
Colorectal Cancer
Interventions
First Posted Date
2004-02-11
Last Posted Date
2018-05-16
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
238
Registration Number
NCT00077233
Locations
🇺🇸

Memorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States

🇺🇸

MBCCOP - University of Illinois at Chicago, Chicago, Illinois, United States

🇺🇸

CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

and more 74 locations

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking

Phase 3
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-02-06
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
1708
Registration Number
NCT00033592
Locations
🇺🇸

Cancer Center of Kansas - Wichita, Wichita, Kansas, United States

🇺🇸

CCOP - Carle Cancer Center, Urbana, Illinois, United States

🇺🇸

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

and more 22 locations

Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2004-02-03
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
59
Registration Number
NCT00008333
Locations
🇺🇸

Siouxland Hematology-Oncology, Sioux City, Iowa, United States

🇺🇸

CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States

🇺🇸

CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States

and more 10 locations

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Phase 1
Terminated
Conditions
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Interventions
Drug: Compound 506U78
First Posted Date
2004-01-29
Last Posted Date
2016-07-04
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
10
Registration Number
NCT00004239
Locations
🇺🇸

Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States

🇺🇸

Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath